Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
PMID 35337071
You should talk to your doctor if you want to switch from one drug product to the other
Limited insurance coverage and affordability issues create barriers to widespread patient access, particularly in lower-income populations and countries with stringent pricing regulations
injectable semaglutide: An indirect treatment comparison of weight loss outcomes
Tirzepatide is already approved to treat type 2 diabetes, and is now approved for chronic weight management in adults with obesity or overweight with at least 1 weight-related condition
US$ 28.57
US$ 29.86
US$ 28.85
US$ 27.41
US$ 21.68
